Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The FY26 story is dominated by two narratives: the ongoing integration of BSV (Bharat Serums & Vaccines, acquired in FY25 for ~13,600 Cr) and the strategic pivot toward chronic and specialty therapies
Consultation with a medical professional is recommended
Recently, Takai et al
High-sensitivity C-reactive proteina powerful predictor of heart attacksdecreased significantly
Unlock a year of full access to The Looker and The Daily Beast for $35
Presented for research literature review only Hamarsheh S et al
%20copy.jpg)
US$ 26.47
US$ 25.01
US$ 27.83
